Minneapolis, MN, United States of America

John J LaRoy

This inventor holds 2 USPTO granted patents. Top assignee: Boston Scientific Scimed, Inc.. Active years: 2021-2026.


% Patents Active = 100.0

Average Co-Inventor Count = 5.5

ph-index = 1


Company Filing History:


Years Active: 2021-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: John LaRoy: Innovator in Vein Closure Technology

Introduction

John LaRoy is a notable inventor based in Minneapolis, MN (US). He has made significant contributions to the field of medical devices, particularly in vein closure technology. His innovative approach has led to the development of a unique implant designed to occlude flow through a vessel.

Latest Patents

John LaRoy holds 1 patent for his invention titled "Devices and methods for vein closure." This patent describes an implant that comprises a body member with a first end portion, a second end portion, and an intermediate rod portion. The implant features a mesh with a base layer and a plurality of micro-pillars extending from a first surface of the base layer. The mesh is designed to be disposed around at least a portion of the body, allowing the micro-pillars to extend radially outward and into adjacent tissue.

Career Highlights

LaRoy is currently associated with Boston Scientific Scimed, Inc., where he continues to work on advancing medical technologies. His expertise in the field has positioned him as a valuable asset to the company and the medical device industry.

Collaborations

Throughout his career, John LaRoy has collaborated with talented professionals, including Patrick A Haverkost and Arman Shahriar. These collaborations have fostered innovation and contributed to the development of cutting-edge medical solutions.

Conclusion

John LaRoy's work in vein closure technology exemplifies the impact of innovation in the medical field. His contributions continue to enhance patient care and improve medical outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…